Biostem Technologies Inc BSEM:OTCPK

RT Quote | Exchange | USD
Last | 02/25/21 EST
1.49UNCH (UNCH)
Volume
10
52 week range
0.01 - 2.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.49
  • 52 Week High2.50
  • 52 Week High Date04/30/20
  • 52 Week Low0.01
  • 52 Week Low Date12/03/20
  • Market Cap13.66M
  • Shares Out9.17M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.69
  • 1 Year % Change14.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.68
  • P/E (TTM)-2.20
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.901M
  • ROE (MRQ)-218.89%
  • Revenue (MRQ)230,000.00
  • Gross Margin (MRQ)54.83%
  • Net Margin (MRQ)-1,858.26%
  • Debt To Equity (MRQ)814.77%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Biostem Technologies Inc News

There is no recent news for this security.

Latest BSEM News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Biostem Technologies, Inc. is a development-stage company. The Company is a biotechnology company focused on the development of anti-aging nutraceutical and cosmeceutical products, stem cell therapies, pharmaceuticals and educational provider of cell treatment protocols. The Company's divisions include Biostem Cell Therapy, Biostem Pharmaceuticals and Biostem Wellness. Biostem Cell Therapy provides stem cell therapies, stem cell banking, stem cell therapy, and stem cell...
Marc Barhonovich
Chief Executive Officer
Leon Willis Jr.
Chief Financial Officer
Address
2836 Center Port Cir
Pompano Beach, FL
33064-2136
United States